Saccharolytic fermentation generates short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate, which promote gut health and influence liver metabolism, potentially mitigating fat accumulation
Serum BDNF levels are consistently lower in patients with major depressive disorder compared to healthy controls, and successful antidepressant treatment normalizes these levels
In some cases, goiter size can shrink significantly with Se supplementation alone, especially in those with both iodine and Se deficiencies
Sources Every claim above traces to peer-reviewed literature indexed on PubMed: Once-Weekly Semaglutide in Adults with Overweight or Obesity PubMed 33567185 Tirzepatide Once Weekly for the Treatment of Obesity PubMed 35658024 Tirzepatide once weekly for obesity in people with type 2 diabetes PubMed 37385275 Tirzepatide as Compared with Semaglutide for the Treatment of Obesity PubMed 40353578 A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management PubMed 26132939 Liraglutide for weight management: a critical review of the evidence PubMed 28392927 Triple-Hormone-Receptor Agonist Retatrutide for Obesity PubMed 37366315 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes PubMed 37385280 Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease PubMed 38858523 Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity PubMed 40544433 Weight regain and cardiometabolic effects after withdrawal of semaglutide PubMed 35441470 Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) PubMed 37952131 GLP-1 receptor agonists: an updated review of head-to-head clinical studies PubMed 33767808 The physiology of glucagon-like peptide 1 PubMed 17928588 Glucagon-Like Peptide-1 Receptor Agonists and Strategies To Improve Their Efficiency PubMed 31050435 The Role of Peptide Hormones Discovered in the 21st Century in the Regulation of Appetite and Metabolism PubMed 34067710 Oral delivery of peptide drugs: barriers and developments PubMed 15984901 Obesity pharmacotherapy: current perspectives and future directions PubMed 23092275 The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism PubMed 11713213 Effects of tesamorelin in HIV-infected patients with abdominal fat accumulation PubMed 20554713 Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients PubMed 25038357 MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation PubMed 36761202 Plasma MOTS-c levels are associated with insulin sensitivity in lean but not obese individuals PubMed 29593067 Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues PubMed 28266027 Regeneration or Risk
Weight of evidence: Overall evidence is Moderate : randomized data show improved cellular GSH with selective functional gains
Simal-Gandara, G
